| Autor: |
Chadban SJ; Royal Prince Alfred Hospital and Charles Perkins Centre, University of Sydney, Sydney, Australia., Ahn C; Seoul National University, Seoul, South Korea., Axelrod DA; University of Iowa, Iowa City, IA., Foster BJ; The Montreal Children's Hospital, McGill University Health Centre, Montreal, Canada., Kasiske BL; Hennepin County Medical Center, Minneapolis, MN., Kher V; Medanta Kidney and Urology Institute, Haryana, India., Kumar D; University Health Network, University of Toronto, Toronto, Canada., Oberbauer R; Medical University of Vienna, Vienna, Austria., Pascual J; Hospital del Mar, Barcelona, Spain., Pilmore HL; Auckland City Hospital, Auckland, New Zealand., Rodrigue JR; Beth Israel Deaconess Medical Center, Boston, MA., Segev DL; Johns Hopkins University School of Medicine, Baltimore, MD., Sheerin NS; Newcastle University, Newcastle, United Kingdom., Tinckam KJ; University Health Network, University of Toronto, Toronto, Canada., Wong G; University of Sydney, Sydney, Australia., Knoll GA; The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, Canada. |
| Abstrakt: |
The 2020 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation is intended to assist health care professionals worldwide who evaluate and manage potential candidates for deceased or living donor kidney transplantation. This guideline addresses general candidacy issues such as access to transplantation, patient demographic and health status factors, and immunological and psychosocial assessment. The roles of various risk factors and comorbid conditions governing an individual's suitability for transplantation such as adherence, tobacco use, diabetes, obesity, perioperative issues, causes of kidney failure, infections, malignancy, pulmonary disease, cardiac and peripheral arterial disease, neurologic disease, gastrointestinal and liver disease, hematologic disease, and bone and mineral disorder are also addressed. This guideline provides recommendations for evaluation of individual aspects of a candidate's profile such that each risk factor and comorbidity are considered separately. The goal is to assist the clinical team to assimilate all data relevant to an individual, consider this within their local health context, and make an overall judgment on candidacy for transplantation. The guideline development process followed the Grades of Recommendation Assessment, Development, and Evaluation (GRADE) approach. Guideline recommendations are primarily based on systematic reviews of relevant studies and our assessment of the quality of that evidence, and the strengths of recommendations are provided. Limitations of the evidence are discussed with differences from previous guidelines noted and suggestions for future research are also provided. |
